Search Results - "Escarcega, Ricardo O"

Pembrolizumab-Associated Cardiotoxicity: A Retrospective Analysis of the FDA Adverse Events Reporting System by Milutinovic, Stefan, Jancic, Predrag, Jokic, Vera, Petrovic, Marija, Dumic, Igor, Rodriguez, Ambar Morales, Tanasijevic, Nikola, Begosh-Mayne, Dustin, Stanojevic, Dragana, Escarcega, Ricardo O, Lopez-Mattei, Juan, Cao, Xiangkun

“…Immune checkpoint inhibitors (ICIs) have been successfully used in the previous decade for the treatment of a variety of malignancies. Adverse events (AEs) can…”
Get full text

Impact of Pre-Procedural Serum Albumin Levels on Outcome of Patients Undergoing Transcatheter Aortic Valve Replacement by Koifman, Edward, MD, Magalhaes, Marco A., MD, Ben-Dor, Itsik, MD, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Fang, Chen, PhD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Negi, Smita I., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Corso, Paul J., MD, Shults, Christian, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Risk assessment for transcatheter aortic valve replacement (TAVR) patients is challenging, and surgical scores do not optimally correlate with outcome. The aim…”
Get full text

Prevalence and Impact of Pulmonary Hypertension on Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement by Barbash, Israel M., MD, Escarcega, Ricardo O., MD, Minha, Sa'ar, MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Goldstein, Steven A., MD, Wang, Zuyue, MD, Okubagzi, Petros, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Limited amount of data suggest that patients with aortic stenosis and pulmonary hypertension (PH) who undergo transcatheter aortic valve replacement (TAVR)…”
Get full text

Carcinoid heart disease: Current understanding and future directions by Patel, Chirdeep, MD, Mathur, Moses, MD, MSc, Escarcega, Ricardo O., MD, Bove, Alfred A., MD, PhD

“…Carcinoid tumors are rare and aggressive malignancies. A multitude of vasoactive agents are central to the systemic effects of these tumors. The additional…”
Get full text

Comparison of treatment strategies for femoro‐popliteal disease: A network meta‐analysis by Koifman, Edward, Lipinski, Michael J., Buchanan, Kyle, Yu Kang, Won, Escarcega, Ricardo O., Waksman, Ron, Bernardo, Nelson L.

“…Objectives We sought to compare treatment strategies in a Bayesian network meta‐analysis of randomized controlled trials. Background Peripheral artery disease…”
Get full text

Meta-Analysis of Direct and Indirect Comparison of Ticagrelor and Prasugrel Effects on Platelet Reactivity by Lhermusier, Thibault, MD, PhD, Lipinski, Michael J., MD, PhD, Tantry, Udaya S., PhD, Escarcega, Ricardo O., MD, Baker, Nevin, MD, Bliden, Kevin P., MBA, Magalhaes, Marco A., MD, Ota, Hideaki, MD, Tian, Wenjie, MD, Pendyala, Lakshmana, MD, Minha, Saar, MD, Chen, Fang, PhD, Torguson, Rebecca, MPH, Gurbel, Paul A., MD, Waksman, Ron, MD

“…Studies have linked on-treatment platelet reactivity (PR) to adverse clinical outcomes. Because new P2Y12 inhibitors (prasugrel and ticagrelor) have been…”
Get full text

Outcome of Left-Sided Cardiac Remodeling in Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation by Magalhaes, Marco A., MD, Koifman, Edward, MD, Torguson, Rebecca, MPH, Minha, Sa'ar, MD, Gai, Jiaxiang, MSPH, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Baker, Nevin C., DO, Wang, Zuyue, MD, Goldstein, Steven, MD, Asch, Federico, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Left-sided cardiac remodeling in patients with severe aortic stenosis (AS) was associated with improved outcome; however, there are scarce data on remodeling…”
Get full text

The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspective by Baker, Nevin C., DO, Ansel, Gary M., MD, Rao, Sunil V., MD, Jolly, Sanjit S., MD, Pichard, Augusto D., MD, Steinberg, Daniel, MD, Lipinski, Michael J., MD, PhD, Escarcega, Ricardo O., MD, Minha, Sa'ar, MD, Lhermusier, Thibault, MD, PhD, Magalhães, Marco A., MD, Waksman, Ron, MD

“…The prevention of major bleeding during percutaneous coronary intervention is one of the most widely discussed and often controversial topics within…”
Get full text

Impact of Baseline Mitral Regurgitation on Short- and Long-Term Outcomes Following Transcatheter Aortic Valve Replacement by Kiramijyan, Sarkis, MD, Magalhaes, Marco A., MD, Koifman, Edward, MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Minha, Sa’ar, MD, Baker, Nevin C., DO, Negi, Smita I., MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Okubagzi, Petros, MD, Asch, Federico M., MD, Gaglia, Michael A., MD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract Background The prevalence of concomitant significant mitral regurgitation (MR) in patients with severe aortic stenosis undergoing transcatheter aortic…”
Get full text

Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement by Kiramijyan, Sarkis, MD, Koifman, Edward, MD, Asch, Federico M., MD, Magalhaes, Marco A., MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Negi, Smita I., MD, Baker, Nevin C., DO, Jerusalem, Zachary D., MD, Gai, Jiaxiang, MSPH, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Wang, Zuyue, MD, Shults, Christian C., MD, Ben-Dor, Itsik, MD, Corso, Paul J., MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The impact of the specific etiology of mitral regurgitation (MR) on outcomes in the transcatheter aortic valve replacement (TAVR) population is unknown. This…”
Get full text

Definitions of Periprocedural Myocardial Infarction as Surrogates for Catheterization Laboratory Quality or Clinical Trial End Points by Baker, Nevin C., DO, Lipinski, Michael J., MD, PhD, Escarcega, Ricardo O., MD, Magalhaes, Marco A., MD, Minha, Sa'ar, MD, Torguson, Rebecca, MPH, Waksman, Ron, MD

“…A consensus on what constitutes a clinically meaningful periprocedural myocardial infarction (PMI) remains highly debated. We evaluated the accuracy of 2 PMI…”
Get full text

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis by Lipinski, Michael J, Benedetto, Umberto, Escarcega, Ricardo O, Biondi-Zoccai, Giuseppe, Lhermusier, Thibault, Baker, Nevin C, Torguson, Rebecca, Brewer, Jr, H Bryan, Waksman, Ron

“…We performed a network meta-analysis of randomized controlled trials (RCTs) in patients with primary hypercholesterolaemia to compare the impact of proprotein…”
Get full text

Aortic Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement with the Self-Expanding CoreValve versus the Balloon-Expandable SAPIEN XT Valve by Kiramijyan, Sarkis, MD, Magalhaes, Marco A., MD, Koifman, Edward, MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Baker, Nevin C., DO, Negi, Smita I., MD, Minha, Sa’ar, MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Asch, Federico M., MD, Wang, Zuyue, MD, Okubagzi, Petros, MD, Gaglia, Michael A., MD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract The incidence of aortic regurgitation (AR) post transcatheter aortic valve replacement (TAVR) among a self-expanding and a balloon-expandable system…”
Get full text

Superior survival with transcatheter core valve over surgery in high-risk patients with aortic stenosis: good news for the Heart Team by Escarcéga, Ricardo O, Waksman, Ron

Get full text

Clinical Utility of Central Venous Saturation for the Calculation of Cardiac Index in Cardiac Patients by Alkhouli, Mohamad, MD, Solaiman, Ahmad Yusef, MD, Zhao, Huaqing, PhD, Morad, Abdulrahman, MD, Escarcega, Ricardo O., MD, O'Murchu, Brian, MD, Bove, Alfred A., MD, PhD

“…Abstract Background Mixed venous saturation (MVS) obtained from the distal pulmonary artery (PA) during Swan-Ganz catheterization is the criterion standard for…”
Get full text

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis by Lipinski, Michael J, Escarcega, Ricardo O, Baker, Nevin C, Benn, Hadiya A, Gaglia, Jr, Michael A, Torguson, Rebecca, Waksman, Ron

“…The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement of an ABSORB…”
Get full text

Evaluating Performance of ChatGPT on MKSAP Cardiology Board Review Questions by Milutinovic, Stefan, Petrovic, Marija, Begosh-Mayne, Dustin, Lopez-Mattei, Juan, Chazal, Richard A., Wood, Malissa J., Escarcega, Ricardo O.

“…Chat Generative Pretrained Transformer (ChatGPT) is a natural language processing tool created by OpenAI. Much of the discussion regarding artificial…”
Get full text

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold by Lipinski, Michael J., MD, PhD, Escarcega, Ricardo O., MD, Baker, Nevin C., DO, Benn, Hadiya A, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Waksman, Ron, MD

“…Abstract Objectives The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement…”
Get full text

Exercise Stress Testing Specificity in Patients With ANOCA: Beware When Applying to a General Population by Escárcega, Ricardo O., Singh, Kamaldeep, Chazal, Richard A., Wood, Malissa J.

Get full text

The Impact of Prior Coronary Intervention on Mortality: Do It Well and Do It Once by Escárcega, Ricardo O.

Get full text